152 related articles for article (PubMed ID: 28511960)
1. Inadequate target volume delineation and local-regional recurrence after intensity-modulated radiotherapy for human papillomavirus-positive oropharynx cancer.
Chen AM; Chin R; Beron P; Yoshizaki T; Mikaeilian AG; Cao M
Radiother Oncol; 2017 Jun; 123(3):412-418. PubMed ID: 28511960
[TBL] [Abstract][Full Text] [Related]
2. Marginal misses after postoperative intensity-modulated radiotherapy for head and neck cancer.
Chen AM; Farwell DG; Luu Q; Chen LM; Vijayakumar S; Purdy JA
Int J Radiat Oncol Biol Phys; 2011 Aug; 80(5):1423-9. PubMed ID: 20656416
[TBL] [Abstract][Full Text] [Related]
3. Origin of tumor recurrence after intensity modulated radiation therapy for oropharyngeal squamous cell carcinoma.
Raktoe SA; Dehnad H; Raaijmakers CP; Braunius W; Terhaard CH
Int J Radiat Oncol Biol Phys; 2013 Jan; 85(1):136-41. PubMed ID: 22541959
[TBL] [Abstract][Full Text] [Related]
4. Variation in radiotherapy target volume definition, dose to organs at risk and clinical target volumes using anatomic (computed tomography) versus combined anatomic and molecular imaging (positron emission tomography/computed tomography): intensity-modulated radiotherapy delivered using a tomotherapy Hi Art machine: final results of the VortigERN study.
Chatterjee S; Frew J; Mott J; McCallum H; Stevenson P; Maxwell R; Wilsdon J; Kelly CG
Clin Oncol (R Coll Radiol); 2012 Dec; 24(10):e173-9. PubMed ID: 23079100
[TBL] [Abstract][Full Text] [Related]
5. Patterns of failure following high-dose 3-D conformal radiotherapy for high-grade astrocytomas: a quantitative dosimetric study.
Lee SW; Fraass BA; Marsh LH; Herbort K; Gebarski SS; Martel MK; Radany EH; Lichter AS; Sandler HM
Int J Radiat Oncol Biol Phys; 1999 Jan; 43(1):79-88. PubMed ID: 9989517
[TBL] [Abstract][Full Text] [Related]
6. Simultaneous 68Ga-DOTATOC-PET/MRI for IMRT treatment planning for meningioma: first experience.
Thorwarth D; Henke G; Müller AC; Reimold M; Beyer T; Boss A; Kolb A; Pichler B; Pfannenberg C
Int J Radiat Oncol Biol Phys; 2011 Sep; 81(1):277-83. PubMed ID: 21300465
[TBL] [Abstract][Full Text] [Related]
7. Two-step Intensity-modulated Radiation Therapy for Oropharyngeal Cancer: Initial Clinical Experience and Validation of Clinical Staging.
Tatebe H; Doi H; Ishikawa K; Kawakami H; Yokokawa M; Nakamatsu K; Kanamori S; Shibata T; Kitano M; Nishimura Y
Anticancer Res; 2018 Feb; 38(2):979-986. PubMed ID: 29374730
[TBL] [Abstract][Full Text] [Related]
8. Intensity-modulated radiation therapy of anal squamous cell carcinoma: Relationship between delineation quality and regional recurrence.
Rouard N; Peiffert D; Rio E; Mahé MA; Delpon G; Marchesi V; Falk AT; Salleron J; Serre AA
Radiother Oncol; 2019 Feb; 131():93-100. PubMed ID: 30773194
[TBL] [Abstract][Full Text] [Related]
9. Prospective Qualitative and Quantitative Analysis of Real-Time Peer Review Quality Assurance Rounds Incorporating Direct Physical Examination for Head and Neck Cancer Radiation Therapy.
Cardenas CE; Mohamed ASR; Tao R; Wong AJR; Awan MJ; Kuruvila S; Aristophanous M; Gunn GB; Phan J; Beadle BM; Frank SJ; Garden AS; Morrison WH; Fuller CD; Rosenthal DI
Int J Radiat Oncol Biol Phys; 2017 Jul; 98(3):532-540. PubMed ID: 28258898
[TBL] [Abstract][Full Text] [Related]
10. Repeat CT imaging and replanning during the course of IMRT for head-and-neck cancer.
Hansen EK; Bucci MK; Quivey JM; Weinberg V; Xia P
Int J Radiat Oncol Biol Phys; 2006 Feb; 64(2):355-62. PubMed ID: 16256277
[TBL] [Abstract][Full Text] [Related]
11. Target volume definition for intensity-modulated radiotherapy after induction chemotherapy and patterns of treatment failure after sequential chemoradiotherapy in locoregionally advanced oropharyngeal squamous cell carcinoma.
Loo SW; Geropantas K; Wilson P; Martin WM; Roques TW
Clin Oncol (R Coll Radiol); 2013 Mar; 25(3):162-70. PubMed ID: 22906546
[TBL] [Abstract][Full Text] [Related]
12. Differential response rates to irradiation among patients with human papillomavirus positive and negative oropharyngeal cancer.
Chen AM; Li J; Beckett LA; Zhara T; Farwell G; Lau DH; Gandour-Edwards R; Vaughan AT; Purdy JA
Laryngoscope; 2013 Jan; 123(1):152-7. PubMed ID: 23008061
[TBL] [Abstract][Full Text] [Related]
13. Patterns of local-regional recurrence after conformal and intensity-modulated radiotherapy for head and neck cancer.
Johansen S; Norman MH; Dale E; Amdal CD; Furre T; Malinen E; Evensen JF
Radiat Oncol; 2017 May; 12(1):87. PubMed ID: 28545588
[TBL] [Abstract][Full Text] [Related]
14. Recurrences near base of skull after IMRT for head-and-neck cancer: implications for target delineation in high neck and for parotid gland sparing.
Eisbruch A; Marsh LH; Dawson LA; Bradford CR; Teknos TN; Chepeha DB; Worden FP; Urba S; Lin A; Schipper MJ; Wolf GT
Int J Radiat Oncol Biol Phys; 2004 May; 59(1):28-42. PubMed ID: 15093896
[TBL] [Abstract][Full Text] [Related]
15. Nodal response after 46 Gy of intensity-modulated radiotherapy is associated with human papillomavirus-related oropharyngeal carcinoma.
Dronkers EAC; Koljenovic S; Verduijn GM; Baatenburg de Jong RJ; Hardillo JAU
Laryngoscope; 2018 Oct; 128(10):2333-2340. PubMed ID: 29521420
[TBL] [Abstract][Full Text] [Related]
16. Patterns of locoregional failure following post-operative intensity-modulated radiotherapy to oral cavity cancer: quantitative spatial and dosimetric analysis using a deformable image registration workflow.
Mohamed ASR; Wong AJ; Fuller CD; Kamal M; Gunn GB; Phan J; Morrison WH; Beadle BM; Skinner H; Lai SY; Quinlan-Davidson SR; Belal AM; El-Gowily AG; Frank SJ; Rosenthal DI; Garden AS
Radiat Oncol; 2017 Aug; 12(1):129. PubMed ID: 28806994
[TBL] [Abstract][Full Text] [Related]
17. Recurrence of head and neck squamous cell carcinoma in relation to high-risk treatment volume.
Nissi L; Suilamo S; Kytö E; Vaittinen S; Irjala H; Minn H
Clin Transl Radiat Oncol; 2021 Mar; 27():139-146. PubMed ID: 33665383
[TBL] [Abstract][Full Text] [Related]
18. Volumetric intensity-modulated arc therapy vs. conventional IMRT in head-and-neck cancer: a comparative planning and dosimetric study.
Verbakel WF; Cuijpers JP; Hoffmans D; Bieker M; Slotman BJ; Senan S
Int J Radiat Oncol Biol Phys; 2009 May; 74(1):252-9. PubMed ID: 19362244
[TBL] [Abstract][Full Text] [Related]
19. Tumor volume as a prognostic marker in p16-positive and p16-negative oropharyngeal cancer patients treated with definitive intensity-modulated radiotherapy.
Carpén T; Saarilahti K; Haglund C; Markkola A; Tarkkanen J; Hagström J; Mattila P; Mäkitie A
Strahlenther Onkol; 2018 Aug; 194(8):759-770. PubMed ID: 29774396
[TBL] [Abstract][Full Text] [Related]
20. Incidence of radiographically occult nodal metastases in HPV+ oropharyngeal carcinoma: Implications for reducing elective nodal coverage.
Loganadane G; Kelly JR; Lee NC; Kann BH; Mahajan A; Hansen JE; Belkacémi Y; Yarbrough W; Husain ZA
Pract Radiat Oncol; 2018; 8(6):397-403. PubMed ID: 29730282
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
